The relatively low frequency of JAK2 mutations in the study may be explained by the applied technique, which is less sensitive than the next generation sequencing implemented in numerous reports, a small study group and the fact that JAK2 mutations in the BCR::ABL1-like ALL may occur in other coding regions. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.